Home / Press Release / Global Electrophysiology Devices Market Expected To Reach US$ 16,730.2 Mn By 2026

Global Electrophysiology Devices Market Expected To Reach US$ 16,730.2 Mn By 2026

The latest market report published by Credence Research, Inc. “Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026” the electrophysiology devices market was valued at US$ 6,513.3 Mn in 2017 and projected to reach US$ 16,730.2 Mn by 2026 at a CAGR of 10.9% over the forecast period from 2018 to 2026.

Browse the full report Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at  https://www.credenceresearch.com/report/electrophysiology-devices-market

Market Insights

The electrophysiology (EP) devices market is likely to witness a phenomenal CAGR during the forecast period from 2018 to 2026. Electrophysiology, the branch of physiology is a test executed to assess the electrical system/activity of the heart and to diagnose abnormal heartbeats or arrhythmia. Growing aging population coupled with rising prevalence of atrial fibrillation (AF) & cardiovascular diseases (CVDs), technological advancements in electrophysiology devices, and the presence of favorable government initiatives are the factors driving the market growth. Technological developments in electrophysiology devices such as fluoroscopy integrated 3D mapping technology in ablation, bidirectional duodecapolar diagnostic catheter, irrigated-tip RF catheters, and remote steering systems are fuelling the demand for adoption of EP devices. In addition, novel techniques including convergent procedure, WATCHMAN left atrial appendage closure (LAAC) procedure, and focal impulse and rotor modulation (FIRM) ablation are gaining the momentum among patients and healthcare professionals (HCPs). On the contrary, high costs of electrophysiology devices and the availability of alternative therapies are anticipated to hinder the market growth during the forecast period.

The introduction of the Million Hearts CVD Risk Reduction model that will bridge a gap in cardiovascular care by means of offering targeted incentives for healthcare providers (HCPs) or practitioners in order to engage in beneficiary cardiovascular disease (CVD) risk calculation and population-level risk management is expected to support the market growth.

Key Market Movements:

Contact Information
24/7 Research Support
Phone: +1-800-361-8290
Get in Touch with us
Join us on Facebook
Follow us on Twitter
Join us on LinkedIn
Add us on Google +